APA (7th ed.) Citation

LUP, L., A, Å., S, S., MD, S., S, H., AM, G., . . . AV, R. (2025). Risk and prognosis of posttransplant lymphoproliferative disease in Epstein-Barr virus-seronegative kidney transplant recipients - an observational cohort study from Norway and western Denmark. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 25(7), 1547. https://doi.org/10.1016/j.ajt.2025.01.035

Chicago Style (17th ed.) Citation

LUP, Ludvigsen, et al. "Risk and Prognosis of Posttransplant Lymphoproliferative Disease in Epstein-Barr Virus-seronegative Kidney Transplant Recipients - an Observational Cohort Study from Norway and Western Denmark." American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 25, no. 7 (2025): 1547. https://doi.org/10.1016/j.ajt.2025.01.035.

MLA (9th ed.) Citation

LUP, Ludvigsen, et al. "Risk and Prognosis of Posttransplant Lymphoproliferative Disease in Epstein-Barr Virus-seronegative Kidney Transplant Recipients - an Observational Cohort Study from Norway and Western Denmark." American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol. 25, no. 7, 2025, p. 1547, https://doi.org/10.1016/j.ajt.2025.01.035.